Picterus Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
2ndary - Private
- Investors
-
10
Picterus General Information
Description
Developer of a smartphone-based neonatal screening tool designed for early detection of jaundice in newborns. The company's platform utilizes a patented color calibration card and an app that ensures correct camera distance, positioning, and quality before capturing images for analysis, enabling healthcare professionals and caregivers with a safer alternative to visual inspection and supporting timely medical intervention for newborns when they are at risk of jaundice.
Contact Information
Website
www.picterus.comCorporate Office
- Kjøpmannsgata 61
- 7011 Trondheim
- Norway
Corporate Office
- Kjøpmannsgata 61
- 7011 Trondheim
- Norway
Picterus Timeline
Picterus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 9. Later Stage VC | 13-Jan-2025 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 19-Apr-2024 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 08-Sep-2023 | Completed | Generating Revenue | |||
| 6. Grant | 28-Aug-2023 | Completed | Generating Revenue | |||
| 5. Grant | 31-Aug-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 09-Aug-2022 | Completed | Generating Revenue | |||
| 3. Grant | 09-Oct-2019 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2019 | $81.9K | $118K | Completed | Generating Revenue | |
| 1. Seed Round | 16-May-2017 | $118K | $118K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Picterus Patents
Picterus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240099649-A1 | Method and system for supporting mothers of newborn infants during breastfeeding | Inactive | 25-Sep-2022 | ||
| GB-201914905-D0 | Method and device for determining the age of a haematoma | Inactive | 15-Oct-2019 | ||
| GB-2588200-A | Method and device for determining the age of a haematoma | Inactive | 15-Oct-2019 | ||
| WO-2021074085-A1 | Method and device for determining the age of a haematoma | Inactive | 15-Oct-2019 | ||
| EP-3393353-A1 | Image based bilirubin determination | Active | 22-Dec-2015 | A61B5/1034 |
Picterus Signals
Picterus Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CVX Ventures | Venture Capital | Minority | ||
| RoundX | Venture Capital | Minority | ||
| TheFactory | Asset Manager | Minority | ||
| Horizon Europe | Not-For-Profit Venture Capital | |||
| E14 Invest | Angel Group | Minority |
Picterus FAQs
-
When was Picterus founded?
Picterus was founded in 2015.
-
Where is Picterus headquartered?
Picterus is headquartered in Trondheim, Norway.
-
What is the size of Picterus?
Picterus has 24 total employees.
-
What industry is Picterus in?
Picterus’s primary industry is Decision/Risk Analysis.
-
Is Picterus a private or public company?
Picterus is a Private company.
-
What is Picterus’s current revenue?
The current revenue for Picterus is .
-
How much funding has Picterus raised over time?
Picterus has raised $4.18M.
-
Who are Picterus’s investors?
CVX Ventures, RoundX, TheFactory, Horizon Europe, and E14 Invest are 5 of 10 investors who have invested in Picterus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process